|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:AZ_Electronic_Materials_(2014)
gptkb:Millipore_(2010)
Sigma-Aldrich (2015)
Versum Materials (2019)
|
|
gptkbp:alsoKnownAs
|
gptkb:EMD_Group_(in_US_and_Canada)
gptkb:Merck_KGaA
|
|
gptkbp:annualReport
|
https://www.merckgroup.com/en/investors/reports-and-financials.html
|
|
gptkbp:CEO
|
gptkb:Belen_Garijo
|
|
gptkbp:competitor
|
gptkb:Bayer
gptkb:Pfizer
gptkb:Merck_&_Co._(US)
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Sanofi
gptkb:Novartis
gptkb:Roche
GlaxoSmithKline
|
|
gptkbp:country
|
gptkb:Germany
|
|
gptkbp:founded
|
1668
|
|
gptkbp:founder
|
gptkb:Friedrich_Jacob_Merck
|
|
gptkbp:headquartersLocation
|
gptkb:Darmstadt,_Germany
|
|
gptkbp:historicalEvent
|
Split from Merck & Co. (US) after World War I
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Merck
|
|
gptkbp:industry
|
life sciences
pharmaceuticals
performance materials
|
|
gptkbp:ISIN
|
DE0006599905
|
|
gptkbp:legalForm
|
Kommanditgesellschaft auf Aktien (KGaA)
|
|
gptkbp:listedSince
|
1995
|
|
gptkbp:memberOf
|
gptkb:DAX_40
|
|
gptkbp:netIncome
|
€3.3 billion (2022)
|
|
gptkbp:notableProduct
|
gptkb:Erbitux
gptkb:Gonal-f
gptkb:Mavenclad
gptkb:Rebif
Life Science reagents
Liquid crystals
|
|
gptkbp:numberOfEmployees
|
2023
~63,000 (2023)
|
|
gptkbp:parentCompany
|
gptkb:Merck_family
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:researchInterest
|
immunology
neurology
oncology
fertility
life science tools
|
|
gptkbp:revenue
|
€22.2 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:MRK.DE
|
|
gptkbp:subsidiary
|
gptkb:EMD_Serono
gptkb:Merck_Life_Science
gptkb:MilliporeSigma
|
|
gptkbp:website
|
https://www.merckgroup.com
|
|
gptkbp:bfsParent
|
gptkb:vaccine
|
|
gptkbp:bfsLayer
|
4
|